2022
DOI: 10.21608/asmj.2022.285476
|View full text |Cite
|
Sign up to set email alerts
|

Development of Novel Antimicrobial Tetracycline Analog B (Iodocycline) by Chemo-Informatics.

Abstract: Background: Bacterial resistance to antibiotics is an overwhelming solemn challenge worldwide. This calls for exploratory for novel origins of antibacterial drugs. Tetracycline resistance is mediated via mutations within the ribosomal binding site and/or the attainment of mobile genetic elements bearing tetracycline-specific resistance genes.The aim of the study: Design of novel antimicrobial tetracycline analogs and screening of their in vitro antibacterial activity. Methodology: Our study type was a screenin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 4 publications
0
4
0
Order By: Relevance
“…The chemo-informatics approach was used to create tetracycline analogue B (iodocycline), which was more active as a bacteriostatic antibacterial agent than tetracycline and thus had less bacterial resistance. In comparison to the chloramphenicol prototype antibiotic, tetracycline analogue B has MICs of less than 10 micrograms/mL for bacterial growth, indicating its potent antibacterial action [ 15 ].…”
Section: Drug Discovery and Designmentioning
confidence: 99%
See 1 more Smart Citation
“…The chemo-informatics approach was used to create tetracycline analogue B (iodocycline), which was more active as a bacteriostatic antibacterial agent than tetracycline and thus had less bacterial resistance. In comparison to the chloramphenicol prototype antibiotic, tetracycline analogue B has MICs of less than 10 micrograms/mL for bacterial growth, indicating its potent antibacterial action [ 15 ].…”
Section: Drug Discovery and Designmentioning
confidence: 99%
“…Informatics Used Application Outcome [15] Chemoinformatics Antibiotic discovery Tetracycline analogue B (iodocycline). More active than tetracycline and less bacterial-resistant.…”
Section: Referencementioning
confidence: 99%
“…The in vitro antibacterial activity of a new tetracycline analogue generated semi-synthetically from Streptomyces species was investigated to determine the minimum inhibitory concentrations (MICs) of growth of several harmful bacteria in Egypt. [14] Tetracycline was purified using aqueous two-phase systems made up of cholinium-based salts and polyethylene glycol, and then modified using chemoinformatics. The chemo-informatics approach was used to create tetracycline analogue B (iodocycline).…”
Section: Chemoinformatics and New Tetracycline Analoguementioning
confidence: 99%
“…In comparison to the chloramphenicol prototype antibiotic, tetracycline analogue B has MICs of less than 10 micrograms/ml for bacterial growth, indicating its potent antibacterial action. [14]…”
Section: Chemoinformatics and New Tetracycline Analoguementioning
confidence: 99%